CRVSCorvus Pharmaceuticals, Inc.
$10.52+79% 1Y
$10.52
$6.0452 weeks$25.52
Is the price fair?
What CRVS's price assumes
- Price / book
- 5.35
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 5.35
- Market capitalisation
- $1.10B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks